Related Experiment Video

Updated: Aug 10, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

A 40-kDa myelin basic protein kinase, distinct from erk1 and erk2, is activated in mitotic HeLa cells

H Heider1, C Hug, J M Lucocq

  • 1Anatomisches Institut, Universität Bern, Switzerland.

European Journal of Biochemistry
|January 15, 1994
PubMed

Insights

A novel 40 kDa kinase phosphorylates myelin basic protein during mitosis in HeLa cells. This kinase activity decreases as mitosis progresses, distinct from known mitogen-activated protein kinases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitosis involves complex regulatory networks controlling cell division.
  • Protein phosphorylation plays a critical role in regulating mitotic progression.
  • Specific kinases involved in mitotic regulation are not fully characterized.

Purpose of the Study:

  • To identify and characterize novel kinases active during mitosis.
  • To investigate the phosphorylation of myelin basic protein during the cell cycle.
  • To determine if known mitogen-activated protein (MAP) kinases are involved in mitotic phosphorylation.

Main Methods:

  • Analysis of phosphorylation activity in mitotic HeLa cells compared to G1 and S phases.
  • Renaturation gel electrophoresis to identify kinase activity in cell lysates.
  • Immunoprecipitation and immunoblotting using antibodies against erk1 and erk2.

Main Results:

  • A 40 kDa protein kinase phosphorylating myelin basic protein was identified in mitotic HeLa cells.
  • This kinase activity peaked early in mitosis and decreased as mitosis progressed, paralleling p34cdc2 kinase activity.
  • Antibodies against erk1 and erk2 did not precipitate or detect the mitotic kinase, and erk1/erk2 showed no activation-dependent electrophoretic shifts.

Conclusions:

  • The identified 40 kDa kinase is distinct from erk1 and erk2, suggesting it is not a canonical MAP kinase.
  • These findings indicate that erk1 and erk2 are not activated during HeLa cell mitosis.
  • The 40 kDa kinase represents either a novel MAP kinase family member or a previously undescribed mitotic kinase.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...